LUMITO (LUMITO) News
Follow LUMITO (LUMITO) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 7 public stories across 3 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Lumito Q3 net income SEK -8.073 million
EARNINGS | Oct 29, 2026, 07:31 AM UTC
M
Lumito Q3 Adjusted Free Cash Flow SEK -252 Thousand
EARNINGS | Oct 29, 2026, 07:31 AM UTC
M
Lumito Reports Q3 Sales of SEK 38K as Loss Narrows
Lumito reported Q3 2026 net sales of SEK 38K (0) and loss after tax of SEK -8.1M (-9.5M). Quarter-end cash was SEK 6.3M; working capital was seen funded into late Q1 2027, partly dependent on TO10 warrant exercise.
EQUITY | Oct 29, 2026, 07:30 AM UTC
L
Lumito Q3 adjusted EPS SEK -1.53
EARNINGS | Oct 29, 2026, 07:30 AM UTC
L
External study demonstrates new application areas for SCIZYS® in immunological research
Lumito AB (publ) (“Lumito” or the “Company”) highlights a recently published, peer-reviewed scientific study in which SCIZYS® has been used to analyse biomarkers in immune cells within a new research area. The study demo
NEWS | Sep 15, 2026, 08:25 AM UTC
L
Lumito wins first non-Nordic order from European university hospital
Lumito AB has received an order from a European university hospital valued at approximately EUR 4,000. It is the company’s first order outside the Nordic region since its commercial launch.
EQUITY | Sep 01, 2026, 08:30 AM UTC
L
Lumito terminates mentorship agreement
Lumito has terminated a mentorship agreement.
EQUITY | Sep 01, 2026, 06:30 AM UTC